380 related articles for article (PubMed ID: 32615090)
21. The relationship between the phageome and human health: are bacteriophages beneficial or harmful microbes?
Fernández L; Duarte AC; Rodríguez A; García P
Benef Microbes; 2021 Apr; 12(2):107-120. PubMed ID: 33789552
[TBL] [Abstract][Full Text] [Related]
22. "I will survive": A tale of bacteriophage-bacteria coevolution in the gut.
De Sordi L; Lourenço M; Debarbieux L
Gut Microbes; 2019; 10(1):92-99. PubMed ID: 29913091
[TBL] [Abstract][Full Text] [Related]
23. A bacteriophages journey through the human body.
Barr JJ
Immunol Rev; 2017 Sep; 279(1):106-122. PubMed ID: 28856733
[TBL] [Abstract][Full Text] [Related]
24. Movers and shakers: influence of bacteriophages in shaping the mammalian gut microbiota.
Mills S; Shanahan F; Stanton C; Hill C; Coffey A; Ross RP
Gut Microbes; 2013; 4(1):4-16. PubMed ID: 23022738
[TBL] [Abstract][Full Text] [Related]
25. The gut environment regulates bacterial gene expression which modulates susceptibility to bacteriophage infection.
Lourenço M; Chaffringeon L; Lamy-Besnier Q; Titécat M; Pédron T; Sismeiro O; Legendre R; Varet H; Coppée JY; Bérard M; De Sordi L; Debarbieux L
Cell Host Microbe; 2022 Apr; 30(4):556-569.e5. PubMed ID: 35421351
[TBL] [Abstract][Full Text] [Related]
26. Three New Escherichia coli Phages from the Human Gut Show Promising Potential for Phage Therapy.
Dalmasso M; Strain R; Neve H; Franz CM; Cousin FJ; Ross RP; Hill C
PLoS One; 2016; 11(6):e0156773. PubMed ID: 27280590
[TBL] [Abstract][Full Text] [Related]
27. Microbiome-phage interactions in inflammatory bowel disease.
Federici S; Kviatcovsky D; Valdés-Mas R; Elinav E
Clin Microbiol Infect; 2023 Jun; 29(6):682-688. PubMed ID: 36191844
[TBL] [Abstract][Full Text] [Related]
28. Gnotobiotic mouse model of phage-bacterial host dynamics in the human gut.
Reyes A; Wu M; McNulty NP; Rohwer FL; Gordon JI
Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20236-41. PubMed ID: 24259713
[TBL] [Abstract][Full Text] [Related]
29. Responses of intestinal virome to silver nanoparticles: safety assessment by classical virology, whole-genome sequencing and bioinformatics approaches.
Gokulan K; Bekele AZ; Drake KL; Khare S
Int J Nanomedicine; 2018; 13():2857-2867. PubMed ID: 29844669
[TBL] [Abstract][Full Text] [Related]
30. Molecular Basis for Lytic Bacteriophage Resistance in Enterococci.
Duerkop BA; Huo W; Bhardwaj P; Palmer KL; Hooper LV
mBio; 2016 Aug; 7(4):. PubMed ID: 27578757
[TBL] [Abstract][Full Text] [Related]
31. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
[TBL] [Abstract][Full Text] [Related]
32. Bacterial Swarm-Mediated Phage Transportation Disrupts a Biofilm Inherently Protected from Phage Penetration.
Ratheesh NK; Zdimal AM; Calderon CA; Shrivastava A
Microbiol Spectr; 2023 Aug; 11(4):e0093723. PubMed ID: 37358420
[TBL] [Abstract][Full Text] [Related]
33. Matrix-trapped viruses can prevent invasion of bacterial biofilms by colonizing cells.
Bond MC; Vidakovic L; Singh PK; Drescher K; Nadell CD
Elife; 2021 Jul; 10():. PubMed ID: 34240700
[TBL] [Abstract][Full Text] [Related]
34. A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota.
Cieplak T; Soffer N; Sulakvelidze A; Nielsen DS
Gut Microbes; 2018; 9(5):391-399. PubMed ID: 29517960
[TBL] [Abstract][Full Text] [Related]
35. The enemy from within: a prophage of Roseburia intestinalis systematically turns lytic in the mouse gut, driving bacterial adaptation by CRISPR spacer acquisition.
Cornuault JK; Moncaut E; Loux V; Mathieu A; Sokol H; Petit MA; De Paepe M
ISME J; 2020 Mar; 14(3):771-787. PubMed ID: 31827247
[TBL] [Abstract][Full Text] [Related]
36. In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli.
Weiss M; Denou E; Bruttin A; Serra-Moreno R; Dillmann ML; Brüssow H
Virology; 2009 Oct; 393(1):16-23. PubMed ID: 19699505
[TBL] [Abstract][Full Text] [Related]
37. Identifying and analyzing bacteriophages in human fecal samples: what could we discover?
Muniesa M; Jofre J
Future Microbiol; 2014; 9(7):879-86. PubMed ID: 25156377
[TBL] [Abstract][Full Text] [Related]
38. Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestine.
Maura D; Galtier M; Le Bouguénec C; Debarbieux L
Antimicrob Agents Chemother; 2012 Dec; 56(12):6235-42. PubMed ID: 23006754
[TBL] [Abstract][Full Text] [Related]
39. Impact of phages on soil bacterial communities and nitrogen availability under different assembly scenarios.
Braga LPP; Spor A; Kot W; Breuil MC; Hansen LH; Setubal JC; Philippot L
Microbiome; 2020 Apr; 8(1):52. PubMed ID: 32252805
[TBL] [Abstract][Full Text] [Related]
40. Coexistence of phage and bacteria on the boundary of self-organized refuges.
Heilmann S; Sneppen K; Krishna S
Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12828-33. PubMed ID: 22807479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
